• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Eledon Pharmaceuticals released FY2025 9 Months Earnings on November 14 (EST), with actual revenue of USD 0 and EPS of USD -0.4555
04:00
Eledon Pharmaceuticals released FY2025 Q3 earnings on November 14, 2025 (EST), with actual revenue USD 0 and EPS USD -0.2259 (forecasted EPS USD -0.2457)
04:00
Nov6
Eledon Pharmaceuticals Reports Positive Results for Tegetprubart's Phase 2 Trial
23:30
Aug15
Eledon Pharmaceuticals released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1453 (forecast USD -0.23)
03:00
Eledon Pharmaceuticals released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.2295
03:00
Jul17
Eledon to Present Tegoprubart's Phase 1b Clinical Trial Update at San Francisco Transplant Conference
20:01

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -17.46 M, EPS -0.2259

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -11.22 M, EPS -0.1453

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -6.495 M, EPS -0.0842

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
28.506
+112.41%
+15.086
PCLA
0.4365
+88.07%
+0.204
ECDA
1.255
+59.87%
+0.472
DTCK
0.3781
+58.93%
+0.140
UPC
6.480
+51.23%
+2.195
MEHA
0.2974
+34.57%
+0.076
FJET
16.165
+30.36%
+3.800
ASPCR
0.2252
+25.11%
+0.045
PAVS
1.944
+23.03%
+0.364
CANF
0.2196
+21.80%
+0.039
View More